News
NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...
19h
Dealbreaker on MSNBioNTech to Pay $740M-Plus to Settle mRNA Patent Disputes, Smooth $1.25 Billion DealAfter BioNTech’s acquisition of CureVac closes, BioNTech will pay GSK another $130 million and a 1% royalty on rest-of-world ...
2hon MSNOpinion
HHS Secretary Robert F. Kennedy Jr. used discredited and misrepresented studies to justify canceling research into ...
HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...
Known as promoter-proximal pausing, this interruption in the transcription activity of RNA polymerase II—the enzyme ...
The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...
The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...
Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA ...
President Trump’s laissez-faire approach is notable, given that the development of the Covid vaccine was seen as one of his ...
New messenger RNA vaccines to fight the coronavirus are based on a technology that could transform medicine. Next up: sickle cell and HIV. On December 23, as part of a publicity push to encourage ...
The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results